Second International Symposium on the Treatment of Parkinson's Disease.
作者信息
Mizuno Y
出版信息
Neurology. 1998 Aug;51(2 Suppl 2):S1. doi: 10.1212/wnl.51.2_suppl_2.s1.
PMID:9711972
Abstract
摘要
相似文献
1
Second International Symposium on the Treatment of Parkinson's Disease.第二届帕金森病治疗国际研讨会
Neurology. 1998 Aug;51(2 Suppl 2):S1. doi: 10.1212/wnl.51.2_suppl_2.s1.
2
Research update on Parkinson's disease and other movement disorders: highlights from the Eighteenth Annual Symposium on the Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders, October 3, 2004, Toronto, Ontario, Canada.帕金森病及其他运动障碍的研究进展：2004年10月3日于加拿大多伦多安大略省举行的第十八届帕金森病及其他运动障碍病因、发病机制与治疗年度研讨会亮点
Rev Neurol Dis. 2005 Winter;2(1):27-9.
3
Parkinson's disease. An overview of treatments and research.帕金森病。治疗与研究概述。
Minn Med. 2001 May;84(5):42-7.
4
Drugs for Parkinson's disease.
Med Lett Drugs Ther. 2017 Nov 20;59(1534):187-194.
5
Parkinson's disease.帕金森病。
Clin Evid. 2002 Jun(7):1208-20.
6
Comparison table: drugs for Parkinson's disease.
Med Lett Drugs Ther. 2017 Nov 20;59(1534):e194-e196.
7
Off and on state assessment of swallowing function in Parkinson's disease.帕金森病吞咽功能的开/关状态评估
Parkinsonism Relat Disord. 2014 Sep;20(9):1033-4. doi: 10.1016/j.parkreldis.2014.06.016. Epub 2014 Jun 25.
8
Future strategies for the treatment of Parkinson's disease.帕金森病的未来治疗策略。
Adv Neurol. 1993;60:636-40.
9
Early, nondisabling Parkinson's disease: weighing the options for initial therapy.
Neurol Clin. 2008 Aug;26(3 Suppl):S1-13, v. doi: 10.1016/j.ncl.2008.05.004.
10
Researchers unite to improve Parkinson's drug discovery.研究人员联合起来改进帕金森病药物研发。
Nat Med. 2010 Mar;16(3):247. doi: 10.1038/nm0310-247b.
引用本文的文献
1
Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.微管相关蛋白tau（MAPT）基因的H1单倍型在希腊帕金森病患者中的作用。
BMC Neurol. 2009 Jun 28;9:26. doi: 10.1186/1471-2377-9-26.
Zotero 插件